These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 7494593)

  • 1. Reaction mixed on value of new FDA regulations for dialyzer relabelling.
    Boudreau D
    Nephrol News Issues; 1995 Oct; 9(10):7-8. PubMed ID: 7494593
    [No Abstract]   [Full Text] [Related]  

  • 2. FDA reconsiders dialyzer relabeling plan after meeting with renal community.
    Neumann M
    Nephrol News Issues; 1994 Jan; 8(1):8, 28. PubMed ID: 8289934
    [No Abstract]   [Full Text] [Related]  

  • 3. FDA NPRM would standardize blood labeling to permit inventory automation.
    McNeal BM
    Health Law Vigil; 1980 Dec; 3(24):6-7. PubMed ID: 10248995
    [No Abstract]   [Full Text] [Related]  

  • 4. Medical devices; hearing aids; technical data amendments. Direct final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2008 Jun; 73(106):31358-60. PubMed ID: 18677822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medicare program; protocol for the reuse of dialysis bloodlines--HCFA. Proposed rule.
    Fed Regist; 1988 Jul; 53(144):28236-39. PubMed ID: 10302616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physical restraints: an FDA update.
    Weick MD
    Am J Nurs; 1992 Nov; 92(11):74-80. PubMed ID: 1485634
    [No Abstract]   [Full Text] [Related]  

  • 7. The FDA as an information source for family physicians.
    Rheinstein PH
    Am Fam Physician; 1991 Sep; 44(3):1037-41. PubMed ID: 1877417
    [No Abstract]   [Full Text] [Related]  

  • 8. FDA: polyurethane condom carries 'extremely misleading' label. Food and Drug Administration.
    AIDS Alert; 1995 Jan; 10(1):1-4. PubMed ID: 11362165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ophthalmic drug products for over-the-counter human use; proposed amendment of final monograph--FDA. Proposed rule.
    Fed Regist; 1998 Feb; 63(35):8888-90. PubMed ID: 10177740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amendment of regulations regarding certain label statements on prescription drugs. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2002 Feb; 67(22):4904-7. PubMed ID: 11829025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On the slow track: the road to FDA approval. Part one of two.
    Boudreau D
    Nephrol News Issues; 1994 Aug; 8(8):16, 18. PubMed ID: 7969545
    [No Abstract]   [Full Text] [Related]  

  • 12. New glutaraldehyde labeling controversial.
    Patterson P
    OR Manager; 1995 Sep; 11(9):26. PubMed ID: 10144942
    [No Abstract]   [Full Text] [Related]  

  • 13. Cold, cough, allergy, bronchodilator, and antiasthmatic drug products for over-the-counter human use; amendment of final monograph for OTC antitussive drug products. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 2000 Aug; 65(148):46864-8. PubMed ID: 11067707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulations requiring manufacturers to assess the safety and effectiveness of new drugs and biological products in pediatric patients--FDA. Final rule.
    Fed Regist; 1998 Dec; 63(231):66631-72. PubMed ID: 10338880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FDA: manufacturers can use available research to verify safety of reuse.
    Neumann ME
    Nephrol News Issues; 1994 Sep; 8(9):9, 11. PubMed ID: 7935894
    [No Abstract]   [Full Text] [Related]  

  • 16. Grace gets FDA OK to import equipment.
    Burns J
    Mod Healthc; 1993 Aug; 23(33):22. PubMed ID: 10127633
    [No Abstract]   [Full Text] [Related]  

  • 17. Osmonics says FDA accepts action plan to correct problems at R.O. plant.
    Nephrol News Issues; 2000 Oct; 14(11):13. PubMed ID: 11933492
    [No Abstract]   [Full Text] [Related]  

  • 18. W.R. Grace division under FDA fire--again.
    Burns J
    Mod Healthc; 1995 Apr; 25(16):9. PubMed ID: 10141539
    [No Abstract]   [Full Text] [Related]  

  • 19. Living day-to-day with kidney dialysis. Quality improvements continue for devices and clinics.
    Williams RD
    FDA Consum; 1998; 32(1):11-5. PubMed ID: 9508544
    [No Abstract]   [Full Text] [Related]  

  • 20. FDA evaluates policy on disposable dialysis device reuse.
    Villforth JC; Miller MJ
    Med Instrum; 1987 Apr; 21(2):107-8. PubMed ID: 3614033
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.